DENISE CERQUEIRA PARANAGUA VEZOZZO

(Fonte: Lattes)
Índice h a partir de 2011
12
Projetos de Pesquisa
Unidades Organizacionais
Instituto Central, Hospital das Clínicas, Faculdade de Medicina - Médico

Resultados de Busca

Agora exibindo 1 - 5 de 5
  • article 14 Citação(ões) na Scopus
    Brazilian society of hepatology recommendations for the diagnosis and treatment of hepatocellular carcinoma
    (2015) CARRILHO, Flair J; MATTOS, Angelo Alves de; VIANEY, Alex F; VEZOZZO, Denise Cerqueira P; MARINHO, Fábio; SOUTO, Francisco J; COTRIM, Helma P; COELHO, Henrique Sergio M; SILVA, Ivonete; GARCIA, José Huygens P; KIKUCHI, Luciana; LOFEGO, Patricia; ANDRAUS, Wellington; STRAUSS, Edna; SILVA, Giovanni; ALTIKES, Isaac; MEDEIROS, Jose Eymard; BITTENCOURT, Paulo L; PARISE, Edison R
    ABSTRACT Hepatocellular carcinoma is a malignancy of global importance and is associated with a high rate of mortality. Recent advances in the diagnosis and treatment of this disease make it imperative to update the recommendations on the management of the disease. In order to draw evidence-based recommendations concering the diagnosis and management of hepatocellular carcinoma, the Brazilian Society of Hepatology has sponsored a single-topic meeting in João Pessoa (PB). All the invited pannelists were asked to make a systematic review of the literature and to present topics related to the risk factors for its development, methods of screening, radiological diagnosis, staging systems, curative and palliative treatments and hepatocellular carcinoma in noncirrhotic liver. After the meeting, all panelists gathered together for the discussion of the topics and the elaboration of those recommendations. The text was subsequently submitted for suggestions and approval of all members of the Brazilian Society of Hepatology through its homepage. The present paper is the final version of the reviewed manuscript containing the recommendations of the Brazilian Society of Hepatology.
  • article 12 Citação(ões) na Scopus
    Significance of CT scan and color Doppler duplex ultrasound in the assessment of Abernethy malformation
    (2015) NACIF, Lucas Souto; PARANAGUA-VEZOZZO, Denise Cerqueira; GALVAO, Flavio Henrique Ferreira; ROCHA, Manoel S.; ANDRAUS, Wellington; CARRILHO, Flair Jose; D'ALBUQUERQUE, Luiz Carneiro
    Background: Abernethy malformation is a rare congenital vascular abnormality in which the portal vein bypasses the liver and drains directly into the inferior vena cava. Diagnosis is complex and requires good quality imaging methods to identify details in systemic and portal circulation in order to establish diagnostic confirmation and treatment strategy. In this study we highlight the significance of the use of CT scans and Color Doppler Duplex Ultrasound for the diagnosis, treatment and evolution assessment in two adults with Abernethy malformation. Case presentation: The diagnosis and the treatment of two patients with Abernethy malformation by CT scan and Color Doppler Duplex Ultrasound is described. One patient was submitted to liver transplantation due to chronic liver disease and multiple nodules diagnosed as adenoma. The other patient had normal liver function and a mild neurological and psychomotor dysfunction, therefore we adopted clinical treatment and close liver parenchyma evaluation and nodule surveillance, using an imaging approach involving intercalating CT scan and Color Doppler Duplex Ultrasound every 6 months. We highlight some important direct and indirect findings of non-invasive imaging methods. Conclusion: Abernethy malformation requires meticulous image diagnosis to improve treatment and avoid iatrogenic procedures. CT scans and Color Doppler Duplex Ultrasound are both efficient methods for diagnosis, treatment planning and evolution assessment of patients with Abernethy malformation.
  • conferenceObject
    Four years real-life experience with antiviral adherence in chronic hepatitis B infection in a tertiary university hospital
    (2015) ABREU, Rodrigo M.; BASSIT, Leda C.; TAO, Sijia; JIANG, Yong; PARANAGUA-VEZOZZO, Denise; SCHINAZI, Raymond F.; CARRILHO, Flair J.; ONO, Suzane K.
  • article 18 Citação(ões) na Scopus
    Hepatocellular Carcinoma Related to Schistosoma mansoni Infection: Case Series and Literature Review
    (2015) TODA, Karla Sawada; KIKUCHI, Luciana; CHAGAS, Aline Lopes; TANIGAWA, Ryan Yukimatsu; PARANAGUA-VEZOZZO, Denise Cerqueira; PFIFFER, Tulio; ROCHA, Manoel de Souza; ALVES, Venancio Avancini Ferreira; CARRILHO, Flair Jose
    Background and Aims: Schistosomiasis is a major chronic disease of humans in endemic regions, and infected individuals may develop a spectrumof pathology, including hepatic fibrosis, hepatosplenomegaly, and portal hypertension. Hepatocellular carcinoma (HCC) is considered the fifth most common cancer in the world, and there is limited and controversial evidence suggesting that Schistosoma mansoni infection may be a possible risk factor for HCC. The aim of this study was to report a case series of patients with HCC and S. mansoni infection and to conduct a literature review on the topic. Methods: From January 2002 to January 2015, an institutional database was screened retrospectively to identify patients with HCC and S. mansoni infection at a single center in the Department of Gastroenterology of University of Sao Paulo School of Medicine and Hospital das Clinicas, Brazil. Results: Seven cases were included. The mean age of patients was 62.1 +/- 10.3 years; six (85.7%) were male and one (14.3%) was female. All cases had positive epidemiology, coming from endemic areas of S. mansoni infection in Brazil, and four (57.1%) had previous complications (upper gastrointestinal bleeding) related toportal hypertension or surgery intervention (splenectomy) performed more than 10 years before the HCC diagnosis. Nontumoral portal vein thrombosis was identified in five (71.4%) patients. All patients had negative serology for HCV, and four (57.1%) had positivity of HBVcore antibodies without evidence of viral replication. According to BCLC staging, one (14.3%) patient was BCLC A and received TACE instead of RFA because HCC size was >30 mm; three (42.8%) BCLC B patients received sorafenib instead of local regional treatment due to the presence of nontumoral TPV. During follow-up, all patients developed tumoral progression and died. Conclusions: It remains unclear if S. mansoni infection alone has carcinogenic potential. The available literature indicates that S. Mansoni, in the presence of HBV and HCV infections, likely acts as a cofactor for the hepatic lesion and potentiates injury.
  • conferenceObject
    IMPACT OF AEROBIC EXERCISE IN POSTMENOPAUSAL WOMEN WITH NONALCOHOLIC FATTY LIVER DISEASE: A 24 WEEKS RANDOMIZED CLINICAL TRIAL
    (2015) REZENDE, R. E.; DUARTE, S. M.; STEFANO, J. T.; PERANDINI, L. A.; DASSOUKI, T.; SA-PINTO, A. L.; ROSCHEL, H.; GUALANO, B.; VEZOZZO, D. C.; CARRILHO, F. J.; OLIVEIRA, C. P.